nephSAP: Volume 9
64
1MB
The concept of a patient-centered medical home (PCMH) is being advanced by a number of specialty societies and by health care policy experts, as well as by both federal and nonfederal payers.
→
Volume 9, Number 1, January 2010
Primary Care for the Nephrologist
Denise M. Dupras, MD, PhD and Ericka E. Tung, MD
AMA PRA Category 1 Credits™
The concept of a patient-centered medical home (PCMH) is being advanced by a number of specialty societies and by health care policy experts, as well as by both federal and nonfederal payers....
75
1.2MB
As reflected by current guidelines, the main purpose of hypertensive therapy is to prevent or at least alleviate end organ damage (1). Such therapeutic goals are ambitious and need trials that extend for several years with thousands of participants.
→
Volume 9, Number 2, March 2010
Hypertension
Raymond T. Townsend, MD and Steven C. Textor, MD
AMA PRA Category 1 Credits™
As reflected by current guidelines, the main purpose of hypertensive therapy is to prevent or at least alleviate end organ damage (1). Such therapeutic goals are ambitious and need trials that extend for several years with thousands of participants....
103
0.8MB
Nephrology is witnessing a period of critical progress in understanding the biology of a subset of noninflammatory glomerular diseases. As reviewed in this issue of NephSAP, there have been several seminal advances in this field during the past 2 years al
→
Volume 9, Number 3, May 2010
Glomerular, Vascular, and Tublointerstitial Diseases
Patrick H. Nachman, MD and Richard J. Glassock, MD
AMA PRA Category 1 Credits™
Nephrology is witnessing a period of critical progress in understanding the biology of a subset of noninflammatory glomerular diseases. As reviewed in this issue of NephSAP, there have been several seminal advances in this field during the past 2 years al...
69
1.4MB
Very infrequently does a new disease suddenly appear in a group of patients who have been closely observed for the past 30 to 40 years. Nonetheless, this occurred in patients with chronic kidney disease (CKD) and ESRD when nephrogenic systemic fibrosis (N
→
Volume 9, Number 4, July 2010
Clinical Pharmacology for the Nephrologist
Suzanne Swan, MD, Ali J. Olyaei, Pharm D, BCPS, and Dominic Sica, MD
AMA PRA Category 1 Credits™
Very infrequently does a new disease suddenly appear in a group of patients who have been closely observed for the past 30 to 40 years. Nonetheless, this occurred in patients with chronic kidney disease (CKD) and ESRD when nephrogenic systemic fibrosis (N...
90
9.1MB
1,25-Dihydroxyvitamin D [1,25(OH)2D] is an important hormone with a number of physiologic and pharmacologic effects on mineral homeostasis (classical effects) as well as on immune function; the vasculature; aging; cell differentiation; and other, nonclass
→
Volume 9, Number 5, September 2010
Disorders of Divalent Ions, Renal Bone Disease, and Nephrolithiasis
Kevin Martin, MBBCh and Stanley Goldfarb, MD
AMA PRA Category 1 Credits™
1,25-Dihydroxyvitamin D [1,25(OH)2D] is an important hormone with a number of physiologic and pharmacologic effects on mineral homeostasis (classical effects) as well as on immune function; the vasculature; aging; cell differentiation; and other, nonclass...
134
1.5MB
The new, expanded bundled payment model for outpatient dialysis services is the consequence of a complicated history of payment that has been due for meaningful reform. Historically, dialysis services were largely reimbursed under an adjusted prospective
→
Volume 9, Number 6, November 2010
End-Stage Renal Disease and Dialysis
Rajiv Agarwal, MD, and Rajnish Mehrotra, MD
AMA PRA Category 1 Credits™
The new, expanded bundled payment model for outpatient dialysis services is the consequence of a complicated history of payment that has been due for meaningful reform. Historically, dialysis services were largely reimbursed under an adjusted prospective ...